|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2008-10-31
|
|
pubmed:abstractText |
We investigated associations between severity of cognitive impairment, cerebrospinal fluid (CSF) concentrations of total-tau (t-tau) protein and tau phosphorylated at threonin 181 (p-tau(181)) and regional glucose metabolism measured with 18F-fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) in patients with probable Alzheimer's disease (AD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1468-1331
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1155-62
|
|
pubmed:meshHeading |
pubmed-meshheading:18803648-Aged,
pubmed-meshheading:18803648-Alzheimer Disease,
pubmed-meshheading:18803648-Biological Markers,
pubmed-meshheading:18803648-Brain,
pubmed-meshheading:18803648-Brain Mapping,
pubmed-meshheading:18803648-Disability Evaluation,
pubmed-meshheading:18803648-Female,
pubmed-meshheading:18803648-Fluorodeoxyglucose F18,
pubmed-meshheading:18803648-Glucose,
pubmed-meshheading:18803648-Humans,
pubmed-meshheading:18803648-Male,
pubmed-meshheading:18803648-Middle Aged,
pubmed-meshheading:18803648-Neuropsychological Tests,
pubmed-meshheading:18803648-Phosphorylation,
pubmed-meshheading:18803648-Positron-Emission Tomography,
pubmed-meshheading:18803648-Predictive Value of Tests,
pubmed-meshheading:18803648-Severity of Illness Index,
pubmed-meshheading:18803648-tau Proteins
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
|
|
pubmed:affiliation |
Max Planck Institute for Neurological Research, Cologne, Germany. haense@nf.mpg.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
